Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arestin in Peri-Implantitis
NCT00662532Phase 3Completed
- Sponsor
- OraPharma
- Start
- Apr 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of minocycline in peri-implantitis, sponsored by OraPharma. Primary endpoint: Probing Depth Reduction at 180 days. Started Apr 2008; status: completed.
02
Drugs
minocycline
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on NCT00662532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00662532.